HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nipon Chattipakorn Selected Research

tabersonine

8/2022Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nipon Chattipakorn Research Topics

Disease

83Mitochondrial Diseases (Mitochondrial Disease)
10/2022 - 05/2011
69Insulin Resistance
10/2022 - 03/2011
62Inflammation (Inflammations)
10/2022 - 05/2011
43Reperfusion Injury
05/2022 - 07/2008
39Obesity
06/2022 - 07/2009
38Iron Overload
01/2022 - 04/2009
36Ischemia
08/2022 - 07/2008
34Cognitive Dysfunction
06/2022 - 10/2014
33Infarction (Infarctions)
05/2022 - 08/2011
24Cardiac Arrhythmias (Arrythmia)
05/2022 - 03/2006
20Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 01/2005
20Left Ventricular Dysfunction
05/2022 - 10/2011
19Heart Failure
08/2022 - 09/2006
19Cardiomyopathies (Cardiomyopathy)
06/2022 - 04/2009
18Myocardial Infarction
10/2021 - 07/2007
17Neoplasms (Cancer)
10/2022 - 02/2015
17Body Weight (Weight, Body)
06/2021 - 07/2009
15Thalassemia
04/2021 - 02/2011
15Ventricular Fibrillation
01/2020 - 05/2003
14Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 07/2008
14Type 2 Diabetes Mellitus (MODY)
01/2022 - 08/2011
11Fibrosis (Cirrhosis)
08/2022 - 06/2015
10Cardiotoxicity
01/2022 - 01/2020
10Alzheimer Disease (Alzheimer's Disease)
01/2022 - 03/2007
10Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 01/2015
9Dysbiosis
01/2022 - 01/2017
7Prediabetic State (Prediabetes)
10/2022 - 10/2018
7Neuroinflammatory Diseases
10/2022 - 01/2021
6Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 04/2008
5Osteoporosis
02/2022 - 02/2016
5Pain (Aches)
02/2022 - 04/2018
5Anemia
01/2021 - 01/2016
5Hyperglycemia
01/2021 - 08/2017
4Encephalitis (Encephalitis, Rasmussen)
08/2022 - 01/2016
4Atrial Fibrillation
01/2022 - 02/2016
4Sepsis (Septicemia)
12/2021 - 12/2016
4Heart Diseases (Heart Disease)
11/2021 - 05/2011
4Infections
11/2021 - 04/2008
4Brain Ischemia (Cerebral Ischemia)
08/2021 - 11/2020
4Stroke (Strokes)
11/2020 - 01/2019
3Chemotherapy-Related Cognitive Impairment
10/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

55Insulin (Novolin)FDA Link
06/2022 - 03/2011
36IronIBA
01/2022 - 04/2009
25Proteins (Proteins, Gene)FDA Link
06/2022 - 09/2006
25Metformin (Glucophage)FDA LinkGeneric
06/2022 - 08/2012
22VildagliptinIBA
01/2019 - 08/2012
18Glucose (Dextrose)FDA LinkGeneric
01/2022 - 07/2009
18Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 05/2011
16Testosterone (Sustanon)FDA Link
12/2020 - 01/2015
15Biomarkers (Surrogate Marker)IBA
05/2022 - 12/2016
15Estrogens (Estrogen)FDA Link
01/2022 - 11/2011
14salicylhydroxamic acid (SHAM)IBA
08/2022 - 12/2014
14CytokinesIBA
05/2022 - 07/2012
13LipidsIBA
10/2022 - 11/2015
13Pharmaceutical PreparationsIBA
10/2022 - 02/2011
13Dipeptidyl-Peptidase IV InhibitorsIBA
12/2018 - 07/2013
11Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 01/2020
11CalciumIBA
01/2022 - 02/2011
11AntioxidantsIBA
08/2019 - 04/2008
10Chelating AgentsIBA
01/2022 - 01/2014
10fibroblast growth factor 21IBA
01/2021 - 11/2015
9Transferrin (beta 2 Transferrin)IBA
01/2022 - 06/2012
8CholesterolIBA
06/2021 - 08/2012
8Insulin ReceptorIBA
01/2019 - 11/2011
7dapagliflozinIBA
10/2021 - 10/2017
7PrebioticsIBA
12/2020 - 01/2017
7Atorvastatin (Lipitor)FDA Link
10/2020 - 01/2016
63- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA
06/2022 - 01/2018
6Galactose (Galactopyranose)FDA LinkGeneric
04/2022 - 01/2018
6T-Type Calcium Channels (T-Type Calcium Channel)IBA
01/2022 - 01/2017
6humaninIBA
01/2022 - 01/2016
6Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022 - 10/2017
6Amyloid beta-PeptidesIBA
01/2021 - 07/2017
6Malondialdehyde (Propanedial)IBA
10/2020 - 06/2012
6DeferiproneIBA
12/2019 - 01/2014
6Indicators and Reagents (Reagents)IBA
06/2018 - 07/2007
6Caspase 3 (Caspase-3)IBA
01/2018 - 05/2013
5MelatoninIBA
05/2022 - 11/2018
5SodiumIBA
01/2022 - 10/2017
5Cysteine (L-Cysteine)FDA Link
12/2020 - 01/2014
5Connexin 43 (Connexin43)IBA
01/2018 - 02/2013
4p38 Mitogen-Activated Protein KinasesIBA
08/2022 - 05/2012
4Lipocalin-2IBA
01/2022 - 01/2018
4Neuroprotective AgentsIBA
01/2022 - 01/2018
4Advanced Glycation End ProductsIBA
01/2022 - 11/2017
4Donepezil (Aricept)FDA LinkGeneric
11/2021 - 01/2021
4Cholinesterase Inhibitors (Anticholinesterases)IBA
11/2021 - 03/2007
4Oxygen (Dioxygen)IBA
08/2021 - 10/2011
4oxidized low density lipoproteinIBA
06/2021 - 01/2019
4Acetylcysteine (Siran)FDA LinkGeneric
01/2020 - 01/2019
4Isoflurophate (DFP)FDA Link
03/2018 - 01/2016
4CreatinineIBA
01/2018 - 01/2016
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2017 - 05/2011
4Ferritins (Ferritin)IBA
11/2016 - 08/2013
4Rosiglitazone (Avandia)FDA Link
05/2013 - 05/2011

Therapy/Procedure

42Therapeutics
05/2022 - 01/2005
13Drug Therapy (Chemotherapy)
01/2022 - 03/2007
10Vagus Nerve Stimulation
01/2022 - 11/2013
6Blood Transfusion (Blood Transfusions)
01/2022 - 02/2011
6Glycemic Control
10/2021 - 07/2013